influenza-a-virus

Documents about influenza-a-virus

• Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults.#481790ClinicalTrials.gov
• Mechanisms of Enhanced Growth of Pandemic H1N1 Influenza A Virus Through PA Mutations#632080UR Research
• Cross-protection against highly pathogenic avian influenza H5N1 virus from seasonal influenza vaccines: a systematic review and meta-analysis of ferret studies#120189Europe PMC
• Case-control Study of Pandemic A/H1N1 Influenza Risk Factors In Lebanon#982233ClinicalTrials.gov
• Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus#148550ClinicalTrials.gov
• Enhanced Efficacy of Oseltamivir Combined With a Jak-Stat Inhibitor for Treatment of an Influenza Virus (Pandemic H1N1) Infection in Mice#169172DigitalCommons@USU
• Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59#911973ClinicalTrials.gov
• Influenza Virus Vaccine Plus Vitamin A and D Supplements for Prevention of Respiratory Virus Infections in Children#424250ClinicalTrials.gov
• Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults#195385ClinicalTrials.gov
• A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere#146259ClinicalTrials.gov
• Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults#184910ClinicalTrials.gov
• A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults#811091ClinicalTrials.gov
• Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors#463752ClinicalTrials.gov
• Confirmation of the Antiviral Effects of Midodrine Identified With a Gene Expression Signature-based Screening of Inluenza A Virus Infected Cells#804480ClinicalTrials.gov
• Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults#332811ClinicalTrials.gov
• Modélisation des dynamiques de co-infections entre virus respiratoires dans l’épithélium respiratoire humain reconstitué#235168HAL (France)
• Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers#377280ClinicalTrials.gov
• A public database to monitor the spread and impacts of high pathogenicity avian influenza viruses on albatrosses and petrels#223775ARPHA OAI-PMH Endpoint
• Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal VLP Quadrivalent Influenza Vaccine in the Elderly Population#28428ClinicalTrials.gov
• Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)#1030157ClinicalTrials.gov
• Characterizing Oseltamivir Use among Community-Dwelling Patients Diagnosed with Influenza Virus Infection, 2023-2025#141243bioRxiv / medRxiv
• Host cell entry and neutralisation sensitivity of H3N2 influenza A virus subclade K.#662843NCBI PubMed Central
• A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.#154731ClinicalTrials.gov
• Circulation of avian influenza viruses in migratory birds in Europe and in Africa: a systematic review#1015728Europe PMC
• Epidemiology of Respiratory Viral Infections at a Combined Influenza and COVID-19 Outpatient Clinic: A Four-Month Cross-Sectional Analysis of Rapid Antigen and RT-PCR Swab Surveillance#382210HAL (France)
• Public health measures during the influenza A(H1N1) 2009 pandemic : WHO technical consultation, Gammarth, Tunisia, 26-28 October 2010 : meeting report#649891WHO IRIS
• Intrinsic OASL expression governs heterogeneity in interferon induction during influenza A virus infection.#323081NCBI PubMed Central
• Genetic Characterization and Pathogenicity of a Triple‐Reassortant H1N1 Swine Influenza Virus Isolated in Guangdong.#4052NCBI PubMed Central
• Blood and Plasma Collection For Use in Future Clinical Trials#429635ClinicalTrials.gov
• Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients#1033569ClinicalTrials.gov
• Colorimetric Detection of SARS-CoV-2 and Drug-Resistant pH1N1 Using CRISPR/dCas9#326602KOASAS: KAIST Open Access Self-Archiving System
• Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older#471490ClinicalTrials.gov
• Comparing outcomes of COVID-19 and influenza among hospitalized adults in the European severe acute respiratory infection vaccine effectiveness (EuroSAVE) network, 2021-2024: a retrospective cohort analysis#202217Europe PMC
• A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines#640446ClinicalTrials.gov
• A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children#184939ClinicalTrials.gov
• Leveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus.#988744NCBI PubMed Central
• Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)#880076ClinicalTrials.gov
• Deciphering HPAI Influenza A Virus (H5N1): Molecular Basis of Pathogenicity, Zoonotic Potential, and Advances in Vaccination Strategies.#140582NCBI PubMed Central
• Identification of <i>cis</i> -Acting Elements that Regulate Influenza A Virus Segment 7 Differential mRNA Splicing#300658Europe PMC
• Mapping the Surveillance Data Infrastructure in the U.S. for SARS-CoV-2, Influenza, and Respiratory Syncytial Virus.#479303NCBI PubMed Central
• Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults#895473ClinicalTrials.gov
• Senolytic Treatment Reduces Acute and Chronic Lung Inflammation in an Aged Mouse Model of Influenza#388116HAL (France)
• Spatial Regulation of Argonaute in Mammalian RNA Interference#202288GUPEA
• Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Children#474811ClinicalTrials.gov
• Dual effects of influenza A virus PA-X on suppression of cytokine signaling and MHC I pathway disruption in the human airway epithelium#474673bioRxiv / medRxiv
• Updated joint FAO/WHO/WOAH public health assessment of recent influenza A(H5) virus events in animals and people#191658FAO Open Knowledge
• Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children#390962ClinicalTrials.gov
• Livestock production intensity and mucosal IgA and IgG responses to H5N1 highly pathogenic avian influenza A virus, North Carolina, 2021-2022#660943bioRxiv / medRxiv
• A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine,(CAIV-T) in Healthy Infants#993432ClinicalTrials.gov
• Vaccination in paediatric, adolescent, and transitional-age rheumatic diseases: a systematic review#477057OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY